| Fair allocation of scarce medical resources in the time of Covid-19 EJ Emanuel, G Persad, R Upshur, B Thome, M Parker, A Glickman, ... New England Journal of Medicine 382 (21), 2049-2055, 2020 | 3135 | 2020 |
| US public attitudes toward COVID-19 vaccine mandates EA Largent, G Persad, S Sangenito, A Glickman, C Boyle, EJ Emanuel JAMA network open 3 (12), e2033324-e2033324, 2020 | 127 | 2020 |
| Severe acute respiratory syndrome: radiographic review of 40 probable cases in Toronto, Canada L Grinblat, H Shulman, A Glickman, L Matukas, N Paul Radiology 228 (3), 802-809, 2003 | 87 | 2003 |
| Reassessing the data on whether a physician shortage exists E Gudbranson, A Glickman, EJ Emanuel Jama 317 (19), 1945-1946, 2017 | 79 | 2017 |
| Measuring the burden of health care costs on US families: the affordability index EJ Emanuel, A Glickman, D Johnson Jama 318 (19), 1863-1864, 2017 | 52 | 2017 |
| Public perspectives on COVID-19 vaccine prioritization G Persad, EJ Emanuel, S Sangenito, A Glickman, S Phillips, EA Largent JAMA network open 4 (4), e217943-e217943, 2021 | 41 | 2021 |
| The current state of evidence on bundled payments A Glickman, C Dinh, A Navathe | 32 | 2018 |
| Drug reimbursement regulation in 6 peer countries EJ Emanuel, C Zhang, A Glickman, E Gudbranson, SSP DiMagno, ... JAMA Internal Medicine 180 (11), 1510-1517, 2020 | 29 | 2020 |
| Accelerated approval of cancer drugs—righting the ship of the US food and drug administration SSP DiMagno, A Glickman, EJ Emanuel JAMA Internal Medicine 179 (7), 922-923, 2019 | 20 | 2019 |
| Next phase in effective cost control in health care A Glickman, SSP DiMagno, EJ Emanuel JAMA 321 (12), 1151-1152, 2019 | 16 | 2019 |
| Prescribing medical cannabis: ethical considerations for primary care providers A Glickman, D Sisti Journal of medical ethics 46 (4), 227-230, 2020 | 13 | 2020 |
| Should pediatric patients be prioritized when rationing life-saving treatments during COVID-19 pandemic RM Antiel, FA Curlin, G Persad, DB White, C Zhang, A Glickman, ... Pediatrics 146 (3), 2020 | 11 | 2020 |
| Medicaid’s institutions for mental diseases (IMD) exclusion rule: a policy debate—argument to repeal the IMD rule A Glickman, DA Sisti Psychiatric Services 70 (1), 7-10, 2019 | 10 | 2019 |
| Dialysis-facility joint-venture ownership—hidden conflicts of interest JS Berns, A Glickman, MS McCoy New England Journal of Medicine 379 (14), 1295-1297, 2018 | 8 | 2018 |
| Measuring the burden of health care costs for working families M McCarthy-Alfano, A Glickman, K Wikelius, J Weiner Health Affairs Forefront, 2019 | 7 | 2019 |
| Conflicts of interest in dialysis: a barrier to policy reforms A Glickman, E Lin, JS Berns Seminars in dialysis 33 (1), 83-89, 2020 | 4 | 2020 |
| Health care cost drivers and options for cost control A Glickman, J Weiner Penn LDI Issue Brief 23 (4), 1-11, 2020 | 3 | 2020 |
| The burden of health care costs for working families A Glickman, J Weiner | 2 | 2019 |
| What Is" Affordable" Health Care? J Weiner, A Glickman | 1 | 2018 |
| Payment and Pricing Decisions in Health Care Reform A Glickman | | 2020 |
